Fate Therapeutics, Inc. Financial Ratios — FATE Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-150.45	-62.69	-48.49	-50.35	-41.06	-42.88	-41.84	-38.09	-37.5	-27.48	-34.63	-26.56	-39.34	-35.89
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	100	- -	100	100	100	100	100	100	100	100	100	100	100
EBITDA Margin (%)	-1,078.72	-485.66	-1,761.48	- -	-1,114.56	-706.09	-1,002.29	-1,390.04	-922.6	-397.65	-378.08	-305.95	-271.09	-1,295.41	-2,028.33
Operating Margin (%)	-1,136.15	-507.75	-1,820.29	- -	-1,142.82	-726.1	-1,025.94	-1,415.44	-943.14	-407.47	-388.56	-320.23	-299.86	-1,434.52	-2,222.45
Incremental Operating Margin (%)	- -	- -	- -	744.49	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-1,147.61	-533.3	-2,151.8	- -	-1,233.73	-760.15	-1,046.08	-1,405.02	-919	-551.59	-379.89	-292.55	-253.3	-1,366.46	-2,051.08
Profit Margin (%)	-1,147.61	-533.3	-2,151.8	- -	-1,233.73	-760.15	-1,046.08	-1,405.02	-919	-551.59	-379.89	-292.55	-253.3	-1,366.46	-2,051.08
Net Income to Common Margin (%)	-1,147.61	-533.3	-2,151.8	- -	-1,233.73	-760.15	-1,046.08	-1,405.02	-919	-551.59	-379.89	-292.55	-253.3	-1,366.46	-2,051.08
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	5	4	2	20	18	11	15	15	27	97	115	109	104	85	78
ST Debt	1	2	2	2	8	8	- -	2	2	3	6	6	6	7	5
LT Debt	4	2	- -	18	11	3	15	12	25	94	109	104	97	78	73
Total Debt/EBITDA	-0.38	-0.28	-0.1	-0.8	-0.67	-0.34	-0.36	-0.23	-0.27	-0.78	-0.54	-0.37	-0.6	-0.48	-0.58
Net Debt/EBITDA	0.12	0.42	3.06	1.21	1.72	2.51	1.8	2.67	1.01	1.34	0.63	0.21	0.24	0.2	0.35
Total Debt/EBIT	-0.36	-0.27	-0.1	-0.79	-0.66	-0.33	-0.35	-0.22	-0.27	-0.76	-0.53	-0.35	-0.54	-0.44	-0.53
Net Debt/EBIT	0.12	0.4	2.96	1.18	1.68	2.44	1.76	2.62	0.99	1.31	0.62	0.2	0.22	0.18	0.32
EBITDA to Interest Expense	-99.38	-26.63	-21.49	-44.46	-12.2	-18.99	-32.46	-38.85	-56.24	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	-99.39	-28.08	-21.79	-46.07	-12.88	-19.27	-33.82	-40.21	-60.46	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	-104.67	-27.84	-22.2	-45.36	-12.51	-19.53	-33.22	-39.56	-57.49	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	1	1	2	2	1	2	2	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-654.29	-592.4	-155.6	-219.55	-209.47	-184.96	-207.75	-133.94	-126.86	-89.46	-83.45	-148.92	-239.35	-317.2	-481.03
Long-Term Debt/Equity (%)	- -	- -	- -	63.77	28.1	3.42	19.18	7.76	10.31	24.44	16.09	21.43	26.43	24.43	35.37
Long-Term Debt/Capital (%)	-7.72	-31.99	- -	-19.48	-8.61	-1.51	-7.26	-4.6	-7.08	-20.44	-16.7	-11.02	-8.79	-5.93	-5.03
Long-Term Debt/Total Assets (%)	45.73	15.64	- -	35.31	15.73	2.63	14.06	5.84	8.35	15.09	11.86	14.7	19.23	17.67	22.98
Total Debt/Equity (%)	-9.55	-6.95	3.41	69.19	47.95	14.61	19.18	9.28	11	25.31	16.91	22.59	28.1	26.75	37.57
Total Debt/Capital (%)	-10.4	-67.83	-2.04	-21.14	-14.69	-6.47	-7.26	-5.5	-7.55	-21.17	-17.55	-11.61	-9.34	-6.5	-5.35
Total Debt/Total Assets (%)	61.63	33.16	3.12	38.31	26.84	11.24	14.06	6.99	8.91	15.63	12.46	15.5	20.45	19.35	24.41
Net Debt to Equity	3.05	10.25	-102.86	-104.07	-122.43	-106.52	-96.06	-109.45	-40.78	-43.53	-19.68	-12.67	-11.36	-11.31	-22.51
Net Debt/Capital (%)	2.93	37.33	37.68	20.79	24.65	30.71	25.31	38.1	21.87	26.69	16.96	6.12	3.64	2.67	3.1
EBITDA	-13	-13	-17	-24	-27	-31	-41	-66	-99	-125	-211	-295	-172	-177	-135
EBITDA-CapEx	-13	-14	-17	-25	-29	-32	-43	-68	-106	-130	-262	-330	-178	-177	-141
Operating Income (Loss)	-13	-14	-18	-25	-28	-32	-42	-67	-101	-128	-217	-308	-191	-196	-148

Liquidity (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	1.74	1.87	11.75	10.74	4.82	6.07	9.14	7.37	7.96	5.64	7.58	3.82	8.06	7.24	5.65
Current Ratio	1.82	2.02	11.88	10.91	4.88	6.14	9.29	7.53	8.17	5.78	7.79	4.4	8.48	7.58	5.79
Quick Ratio	1.74	1.87	11.75	10.74	4.82	6.07	9.14	7.39	7.96	5.71	7.68	4.16	8.11	7.34	5.67
CFO/Avg Current Liab	- -	-3.11	-3.25	-4.89	-2.04	-2.08	-2.81	-2.02	-3.02	-0.69	-1.95	-2.54	-1.73	-3.17	-2.84
Common Equity/Total Assets	-654.29	-592.4	-155.6	-219.55	-209.47	-184.96	-207.75	-133.94	-126.86	-89.46	-83.45	-148.92	-239.35	-317.2	-481.03
Long-Term Debt/Equity (%)	- -	- -	- -	63.77	28.1	3.42	19.18	7.76	10.31	24.44	16.09	21.43	26.43	24.43	35.37
Long-Term Debt/Capital (%)	-7.72	-31.99	- -	-19.48	-8.61	-1.51	-7.26	-4.6	-7.08	-20.44	-16.7	-11.02	-8.79	-5.93	-5.03
Long-Term Debt/Total Assets (%)	45.73	15.64	- -	35.31	15.73	2.63	14.06	5.84	8.35	15.09	11.86	14.7	19.23	17.67	22.98
Total Debt/Equity (%)	-9.55	-6.95	3.41	69.19	47.95	14.61	19.18	9.28	11	25.31	16.91	22.59	28.1	26.75	37.57
Total Debt/Capital (%)	-10.4	-67.83	-2.04	-21.14	-14.69	-6.47	-7.26	-5.5	-7.55	-21.17	-17.55	-11.61	-9.34	-6.5	-5.35
Total Debt/Total Assets (%)	61.63	33.16	3.12	38.31	26.84	11.24	14.06	6.99	8.91	15.63	12.46	15.5	20.45	19.35	24.41
CFO/Total Liabilities	-20.75	-20.77	-324.67	-98.14	-61.49	-136.22	-131.01	-73.53	-144.61	-16.48	-67.13	-112	-95.98	-100.74	-94.93
CFO/CapEx	-6,072.5	-18.72	-63	-25.42	-12.28	-65.26	-21.34	-16.78	-11.25	-7.95	-3.21	-6.98	-21.5	-168.32	-17.82
Altman's Z-Score	-14.14	-11.56	2.56	-0.92	-1.6	-0.48	2.33	6.34	11.87	17.79	12.54	-0.09	-2.17	-4.26	-6.97

Working Capital (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	18.96	42.72	11.4	7.87	4.08	3.15	5.08	2.98
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	19.25	8.54	32.02	46.37	89.37	115.78	71.83	122.33
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	37	103	86	80	257	721	1,334	7,491	5,544	977	368	188	117
- Cash & Cash Equivalents	6	9	54	49	65	89	89	191	100	167	134	61	42	36	47
+ Preferred Equity and Hybrid Capital	- -	57	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	5	4	2	20	18	11	15	15	27	97	115	109	104	85	78
Enterprise Value	-2	51	-15	73	39	-2	170	535	1,140	7,106	5,043	650	156	-6	-9
Total Capital	-47	-5	-85	-93	-124	-165	-204	-270	-357	-460	-654	-941	-1,108	-1,313	-1,456
Total Debt/Capital (%)	-10.4	-67.83	-2.04	-21.14	-14.69	-6.47	-7.26	-5.5	-7.55	-21.17	-17.55	-11.61	-9.34	-6.5	-5.35
Total Debt / EV	-3.13	0.07	-0.11	0.27	0.46	-6.22	0.09	0.03	0.02	0.01	0.02	0.17	0.66	-13.71	-8.57
EV/Sales	- -	19.14	- -	- -	16.17	- -	41.49	112.84	106.74	226.05	90.29	6.75	2.46	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	37	103	86	80	257	721	1,334	7,491	5,544	977	368	188	117
Diluted Enterprise Value	-2	51	-15	73	39	2	182	545	1,262	7,421	5,525	1,025	430	237	148
EV per Share	- -	5.76	- -	3.59	1.54	- -	4.06	9.52	16.72	86.25	53.22	6.71	1.59	- -	- -
TTM Sales	1	3	1	- -	2	4	4	5	11	31	56	96	64	14	7
TTM EBITDA	-13	-13	-17	-24	-27	-31	-41	-66	-99	-125	-211	-295	-172	-177	-135
TTM Operating Income	-13	-14	-18	-25	-28	-32	-42	-67	-101	-128	-217	-308	-191	-196	-148
TTM Cash Flow to Firm	-12	-13	-15	-22	-16	-28	-36	-37	-81	-39	-163	-248	-132	-123	-106
TTM Free Cash Flow to Firm	-12	-12	-14	-21	-15	-28	-34	-35	-74	-34	-112	-213	-126	-122	-100

Multiples (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	-2.45	-4.78	-5.08	-2.71	-7.31	-19.84	-17.61	-218.42	-49.42	-4.59	-2.92	-1.54	-1.17
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-2	51	-15	73	39	-2	170	535	1,140	7,106	5,043	650	156	-6	-9
Low Price	- -	- -	4.3	3.5	3.12	1.46	2.44	5.9	11.7	16.75	43.6	9.56	1.63	1.55	0.66
EV/Sales	- -	19.14	- -	- -	16.17	- -	41.49	112.84	106.74	226.05	90.29	6.75	2.46	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-1.78	-4.91	-4.67	-2.13	-3.75	-9.79	-11.97	-18.13	-34.68	-9.78	-2.63	-2.58	-1.02
Price/Earnings High	- -	- -	-2.59	-10.71	-7.46	-3.63	-6.6	-15.17	-15.85	-49.25	-54.11	-20.77	-7	-5.39	-1.73
Price/Earnings Low	- -	- -	-1.21	-2.77	-2.65	-1.39	-2.38	-4.98	-8.13	-7.96	-19.47	-3.29	-1	-0.95	-0.58
Price/Book Value	- -	- -	-0.43	-0.92	-0.6	-0.45	-1.17	-2.53	-3.48	-13.45	-7.21	-0.93	-0.3	-0.13	-0.08
Price/Book Value Average	- -	- -	-0.43	-1.13	-0.98	-0.41	-0.74	-2.29	-3.06	-5.65	-9.57	-2.62	-0.35	-0.34	-0.09
Price/Book Value High	- -	- -	-0.63	-2.47	-1.57	-0.69	-1.3	-3.54	-4.06	-15.34	-14.93	-5.57	-0.93	-0.72	-0.15
Price/Book Value Low	- -	- -	-0.29	-0.64	-0.56	-0.26	-0.47	-1.16	-2.08	-2.48	-5.37	-0.88	-0.13	-0.13	-0.05
Price/Tangible Book Value	- -	- -	0.73	3.63	2.26	1.09	3.32	4.49	5.45	19.49	8.17	2.02	1	0.59	0.56
Price/Tangible Book Value Average	- -	- -	0.73	4.49	3.68	0.97	2.09	4.06	4.8	8.18	10.84	5.69	1.15	1.51	0.67
Price/Tangible Book Value High	- -	- -	1.07	9.78	5.88	1.66	3.67	6.3	6.36	22.21	16.91	12.09	3.06	3.15	1.14
Price/Tangible Book Value Low	- -	- -	0.5	2.53	2.09	0.63	1.33	2.07	3.26	3.59	6.09	1.91	0.44	0.55	0.38
Price/Sales	- -	- -	38.13	- -	35.33	18.11	62.47	152.11	124.95	238.32	99.27	10.15	5.79	13.76	17.56
Price/Sales Average	- -	- -	38.23	- -	57.63	16.19	39.25	137.58	110	100.01	131.75	28.62	6.65	35.2	20.84
Price/Sales High	- -	- -	55.8	- -	92.04	27.56	69.02	213.16	145.7	271.68	205.56	60.76	17.72	73.64	35.57
Price/Sales Low	- -	- -	26.11	- -	32.71	10.53	24.95	69.95	74.7	43.9	73.97	9.61	2.52	12.93	11.82
Price/Cash Flow	- -	- -	-2.41	-4.59	-4.67	-2.67	-6.97	-18.65	-16.04	-190.96	-34.04	-3.94	-2.78	-1.53	-1.1
Price/Cash Flow Average	- -	- -	-2.41	-5.67	-7.62	-2.39	-4.38	-16.87	-14.12	-80.14	-45.18	-11.1	-3.2	-3.91	-1.31
Price/Cash Flow High	- -	- -	-3.52	-12.36	-12.16	-4.07	-7.7	-26.14	-18.71	-217.7	-70.48	-23.57	-8.51	-8.17	-2.23
Price/Cash Flow Low	- -	- -	-1.65	-3.19	-4.32	-1.55	-2.78	-8.58	-9.59	-35.18	-25.36	-3.73	-1.21	-1.43	-0.74
Price/Free Cash Flow Average	- -	- -	-2.45	-5.91	-8.29	-2.43	-4.59	-17.94	-15.5	-91.67	-65.6	-12.96	-3.35	-3.93	-1.38
Price/Free Cash Flow High	- -	- -	-3.58	-12.87	-13.24	-4.13	-8.08	-27.8	-20.53	-249	-102.34	-27.52	-8.93	-8.22	-2.36
Price/Free Cash Flow Low	- -	- -	-1.68	-3.32	-4.71	-1.58	-2.92	-9.12	-10.53	-40.24	-36.83	-4.35	-1.27	-1.44	-0.78
EV/Sales Average	- -	19.14	- -	- -	38.47	- -	21.19	100.53	103.17	97.79	131.41	29.12	7.62	38.81	25.53
EV/Sales High	- -	19.14	1.94	- -	72.88	9.86	50.96	176.11	138.88	269.45	205.22	61.26	18.69	77.25	40.27
EV/Sales Low	- -	19.14	- -	- -	13.55	- -	6.89	32.9	67.88	41.67	73.64	10.11	3.5	16.54	16.51
EV/EBITDA Average	0.12	-3.94	0.89	-4	-3.45	0.21	-2.11	-7.23	-11.18	-24.59	-34.76	-9.52	-2.81	-3	-1.26
EV/EBITDA High	0.12	-3.94	-0.11	-10.15	-6.54	-1.4	-5.08	-12.67	-15.05	-67.76	-54.28	-20.02	-6.89	-5.96	-1.99
EV/EBITDA Low	0.12	-3.94	1.58	-1.72	-1.22	1.02	-0.69	-2.37	-7.36	-10.48	-19.48	-3.3	-1.29	-1.28	-0.81
EV/EBIT Average	0.12	-3.77	0.86	-3.92	-3.37	0.21	-2.07	-7.1	-10.94	-24	-33.82	-9.09	-2.54	-2.71	-1.15
EV/EBIT High	0.12	-3.77	-0.11	-9.94	-6.38	-1.36	-4.97	-12.44	-14.73	-66.13	-52.82	-19.13	-6.23	-5.39	-1.81
EV/EBIT Low	0.12	-3.77	1.52	-1.69	-1.19	0.99	-0.67	-2.32	-7.2	-10.23	-18.95	-3.16	-1.17	-1.15	-0.74
Last Price	- -	- -	6.28	5.03	3.37	2.51	6.11	12.83	19.57	90.93	58.51	10.09	3.74	1.65	0.98
High Price	- -	- -	9.19	13.55	8.78	3.82	6.75	17.98	22.82	103.66	121.16	60.43	11.44	8.83	1.99
Enterprise Value Average	-2	51	-15	98	94	-7	87	477	1,102	3,074	7,339	2,804	484	529	170
Enterprise Value High	-2	51	2	248	177	43	209	835	1,483	8,470	11,461	5,899	1,187	1,053	268
Enterprise Value Low	-2	51	-27	42	33	-32	28	156	725	1,310	4,112	974	222	225	110

Shares Outstanding	19	19	20	21	29	41	53	65	76	88	96	97	99	114	115
Diluted Weighted Avg Shares	9	9	6	20	25	32	42	56	68	82	95	97	98	114	119
Basic Weighted Avg Shares	9	9	6	20	25	32	42	56	68	82	95	97	98	114	119
Revenue per Share	0.13	0.3	0.16	- -	0.1	0.14	0.1	0.08	0.16	0.38	0.59	0.99	0.65	0.12	0.06
EBITDA per Share	-1.42	-1.46	-2.9	-1.19	-1.06	-0.98	-0.98	-1.17	-1.44	-1.52	-2.23	-3.04	-1.75	-1.55	-1.13
Operating Income per Share	-1.5	-1.53	-3	-1.22	-1.09	-1.01	-1	-1.19	-1.48	-1.55	-2.29	-3.18	-1.94	-1.72	-1.24
Basic EPS, GAAP	-1.51	-1.61	-3.54	-1.27	-1.18	-1.05	-1.02	-1.19	-1.44	-2.1	-2.24	-2.91	-1.64	-1.64	-1.15
Basic EPS from Cont Ops	-1.51	-1.61	-3.54	-1.27	-1.18	-1.05	-1.02	-1.19	-1.44	-2.1	-2.24	-2.91	-1.64	-1.64	-1.15
Diluted EPS, GAAP	-1.51	-1.61	-3.54	-1.27	-1.18	-1.05	-1.02	-1.19	-1.44	-2.1	-2.24	-2.91	-1.64	-1.64	-1.15
Diluted EPS from Cont Ops	-1.51	-1.61	-3.54	-1.27	-1.18	-1.05	-1.02	-1.19	-1.44	-2.1	-2.24	-2.91	-1.64	-1.64	-1.15
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-1.37	-1.5	-2.61	-1.1	-0.72	-0.94	-0.88	-0.69	-1.22	-0.48	-1.72	-2.56	-1.34	-1.08	-0.89
Free Cash Flow per Basic Share	-1.37	-1.58	-2.65	-1.14	-0.78	-0.95	-0.92	-0.73	-1.33	-0.54	-2.25	-2.93	-1.41	-1.09	-0.94
Cash & Equivalents per Share	0.72	1.02	9.16	2.4	2.54	2.9	2.4	3.58	3.25	5.86	6.5	4.51	3.2	2.45	1.71
Book Value per Share	-5.79	-7.4	-14.67	-5.49	-5.59	-5.54	-5.21	-5.08	-5.62	-6.76	-8.12	-10.85	-12.31	-12.3	-12.92
Tangible Book Value per Share	-5.72	-12.33	8.62	1.39	1.49	2.3	1.84	2.86	3.59	4.67	7.16	5	3.74	2.8	1.74

Fate Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)